Written question asked by Lord Warner (Crossbench) on Monday, 19 June 2023, in the House of Lords. It was due for an answer on Monday, 3 July 2023. It was answered by Lord Markham (Conservative) on Tuesday, 27 June 2023 on behalf of the Department of Health and Social Care.
Voluntary Scheme for Branded Medicines Pricing and Access
- Question
-
To ask His Majesty's Government what volume of sales under the Voluntary Scheme for Branded Medicines Pricing and Access are off-patent medicines; and how the suppliers of such medicines are represented in negotiations for the next scheme.
- Answer
-
The information requested is not held centrally. It would not be appropriate for us to comment on a representation of the off-patent sector as this is closely connected with an ongoing legal case.
Secondary information
- Type
- Written question
- Reference
- HL8632
- Session
- 2022-23
- Related items
-
Voluntary Scheme for Branded Medicines Pricing and Access
Tuesday, 25 July 2023
Written questions
House of Lords
-
Voluntary Scheme for Branded Medicines Pricing and Access
Tuesday, 25 July 2023
Written questions
House of Lords
- Subjects
- Drugs Generic prescribing Voluntary scheme for branded medicines pricing and access
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-07-25 16:43:27 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2022-23/HL8632
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2022-23/HL8632
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2022-23/HL8632